[AKRO] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
12-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -115.19%
YoY- -39.52%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -16,207 -11,886 -15,611 -15,554 -7,228 -5,362 -61,472 -58.91%
Tax -1,323 -1,237 -46 -16,309 -7,609 -5,362 -2,968 -41.67%
NP -16,207 -11,886 -15,611 -15,554 -7,228 -5,362 -61,472 -58.91%
Tax Rate - - - - - - - -
Total Cost 16,207 11,886 15,611 15,554 7,228 5,362 61,472 -58.91%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.57 -0.42 -0.55 -0.56 -2.21 -0.20 -2.90 -66.22%
EPS Diluted -0.57 -0.42 -0.55 -0.56 -2.21 -0.20 -2.90 -66.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.